Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892-1210, USA.
BJU Int. 2012 Dec;110(11 Pt B):E783-8. doi: 10.1111/j.1464-410X.2012.11646.x. Epub 2012 Nov 6.
What's known on the subject? and What does the study add? Over-treatment of indolent prostate cancer lesions is a problem which can result in increased human and medical costs. Lesions with a low suspician level at mpMRI of the prostate have low risk of including high risk prostate cancer.
To determine whether multiparametric magnetic resonance imaging (mpMRI) has the potential to identify patients at low risk for cancer, thus obviating the need for biopsy. Prostate cancer is currently diagnosed by random biopsies, resulting in the discovery of multiple low-risk cancers that often lead to overtreatment.
We reviewed 800 consecutive patients who underwent a 3 Tesla mpMRI of the prostate with an endorectal coil from March 2007 to November 2011. All suspicious lesions were independently reviewed by two radiologists using T2-weighted, diffusion-weighted, spectroscopic and dynamic contrast-enhanced MRI sequences. Patients with only low suspicion lesions (maximum of two positive parameters on mpMRI) who subsequently underwent transrectal ultrasonography (TRUS)/MRI fusion targeted biopsy were selected for analysis.
In total, 125 patients with only low suspicion prostatic lesions on mpMRI were identified. On TRUS/MRI fusion biopsy, 77 (62%) of these patients had no cancer detected, 38 patients had Gleason 6 disease and 10 patients had Gleason 7 (3+4) disease. There were 30 patients with cancer detected on biopsy who qualified for active surveillance using 2011 National Comprehensive Cancer Network guidelines. No cases of high-risk (≥ Gleason 4+3) cancer were identified on biopsy and, of the fifteen patients who underwent radical prostatectomy at our institution, none were pathologically upgraded to high-risk cancer. Thus, for patients with only low suspicion lesions, 107 (88%) patients either had no cancer or clinically insignificant disease.
The results obtained in the present study show that low suspicion lesions on mpMRI are associated with either negative biopsies or low-grade tumours suitable for active surveillance. Such patients have a low risk of harbouring high-risk prostate cancers.
确定多参数磁共振成像(mpMRI)是否有可能识别出癌症风险低的患者,从而避免活检的需要。目前,前列腺癌是通过随机活检诊断的,这导致发现了许多低风险的癌症,这些癌症往往导致过度治疗。
我们回顾了 2007 年 3 月至 2011 年 11 月期间 800 例连续接受 3T 直肠内线圈前列腺 mpMRI 的患者。所有可疑病灶均由两名放射科医生使用 T2 加权、弥散加权、波谱和动态对比增强 MRI 序列独立进行回顾。选择仅在 mpMRI 上具有低度可疑病灶(mpMRI 上最多有两个阳性参数)且随后接受经直肠超声(TRUS)/MRI 融合靶向活检的患者进行分析。
总共在 mpMRI 上发现 125 例患者仅有低度可疑前列腺病灶。在 TRUS/MRI 融合活检中,这些患者中有 77 例(62%)未发现癌症,38 例患者有 Gleason 6 级疾病,10 例患者有 Gleason 7(3+4)级疾病。有 30 例活检中发现的癌症患者符合 2011 年国家综合癌症网络指南的主动监测标准。活检中未发现任何高危(≥Gleason 4+3)癌症病例,在我们机构进行根治性前列腺切除术的 15 例患者中,无一例病理升级为高危癌症。因此,对于仅具有低度可疑病灶的患者,107 例(88%)患者要么没有癌症,要么没有临床意义的疾病。
本研究的结果表明,mpMRI 上的低度可疑病灶与阴性活检或适合主动监测的低级别肿瘤相关。这些患者发生高危前列腺癌的风险较低。